← Back to catalogue

BD BBL™ VDRL Antigen

FDA UDI

Class II (US FDA UDI)

by Becton Dickinson And Company

Identity

Trade Name
BD BBL™ VDRL Antigen FDA UDI
Generic Name
Treponema pallidum reagin antibody IVD, kit, agglutination FDA UDI
Device Name
BD BBL™ VDRL Antigen FDA UDI
Model / Reference
240764 FDA UDI
Description
BD BBL™ VDRL Antigen FDA UDI

Identifiers

Catalog Number
240764 FDA UDI
Primary DI / UDI-DI
00382902407645 FDA UDI
FDA Product Code
GMQ FDA UDI
GMDN Term
Treponema pallidum reagin antibody IVD, kit, agglutination FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.3820 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Treponema pallidum reagin antibody IVD, kit, agglutination

BD BBL™ VDRL Antigen by Becton Dickinson And Company — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Treponema pallidum reagin antibody IVD, kit, agglutination.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 1b5e9b8a-6a27-4f1f-a6fa-a0046db9beff 36 fields · synced Jun 8, 2026